Age-associated alterations in the time-dependent profile of pro- and anti-inflammatory proteins within the hippocampus in response to acute exposure to interleukin-1β

Journal of Neuroimmunology

Volumn 267, Issue 1-2, 2014, Pages 86-91

  Hopp, Sarah C ^a   Royer, Sarah ^a   Brothers, Holly M ^a   Kaercher, Roxanne M ^a   D'Angelo, Heather ^a   Bardou, Isabelle ^a   Wenk, Gary L ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Aging; Cytokines; Hippocampus; Microglia; Neuroinflammation; Rat

Indexed keywords

INTERLEUKIN 1BETA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

AGED; AGING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; GENE EXPRESSION; HIPPOCAMPUS; IMMUNE RESPONSE; MALE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

AGING; CYTOKINES; HIPPOCAMPUS; MICROGLIA; NEUROINFLAMMATION; RAT;

AGING; ANALYSIS OF VARIANCE; ANIMALS; CYTOKINES; GENE EXPRESSION REGULATION; HIPPOCAMPUS; INTERLEUKIN-1BETA; MALE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, INBRED F344; RECEPTORS, CXCR3; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TIME FACTORS;

EID: 84893709560     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.12.010     Document Type: Article

References (28)

1. Akiyama H., Arai T., Kondo H., Tanno E., Haga C., Ikeda K. Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Dis. Assoc. Disord. 2000, 14(Suppl. 1):S47-S53.
2. Aloisi F., Penna G., Cerase J., Menéndez Iglesias B., Adorini L. IL-12 production by central nervous system microglia is inhibited by astrocytes. J. Immunol. 1997, 159(4):1604-1612.
3. Bachstetter A.D., Xing B., De Almeida L., Dimayuga E.R., Watterson D.M., Van Eldik L.J. Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ). J. Neuroinflammation 2011, 8:79.
4. Basu A., Krady J.K., Enterline J.R., Levison S.W. Transforming growth factor beta1 prevents IL-1beta-induced microglial activation, whereas TNFalpha- and IL-6-stimulated activation are not antagonized. Glia 2002, 40(1):109-120.
5. Boche D., Perry V.H., Nicoll J.A.R. Review: activation patterns of microglia and their identification in the human brain. Neuropathol. Appl. Neurobiol. 2013, 39(1):3-18.
6. Brook M., Sully G., Clark A.R., Saklatvala J. Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade. FEBS Lett. 2000, 483(1):57-61.
7. Cagnin A., Brooks D.J., Kennedy A.M., Gunn R.N., Myers R., Turkheimer F.E., Jones T., et al. In-vivo measurement of activated microglia in dementia. Lancet 2001, 358(9280):461-467.
8. Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S.M., Dijkstra I.M., Huang D.R., et al. Control of microglial neurotoxicity by the fractalkine receptor. Nature neuroscience 2006, 9(7):917-924.
9. Cerbai F., Lana D., Nosi D., Petkova-Kirova P., Zecchi S., Brothers H.M., Wenk G.L., et al. The neuron-astrocyte-microglia triad in normal brain ageing and in a model of neuroinflammation in the rat hippocampus. PloS one 2012, 7(9):e45250.
10. Colton C.A. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol. 2009, 4:399-418.
11. Colton C.A., Mott R.T., Sharpe H., Xu Q., Van Nostrand W.E., Vitek M.P. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J. Neuroinflammation 2006, 3:27.
12. Fenn A.M., Henry C.J., Huang Y., Dugan A., Godbout J.P. Lipopolysaccharide-induced interleukin (IL)-4 receptor-α expression and corresponding sensitivity to the M2 promoting effects of IL-4 are impaired in microglia of aged mice. Brain Behav. Immun. 2012, 26(5):766-777.
13. Frank-Cannon T.C., Alto L.T., McAlpine F.E., Tansey M.G. Does neuroinflammation fan the flame in neurodegenerative diseases?. Mol. Neurodegener. 2009, 4:47.
14. Greenhalgh C.J., Bertolino P., Asa S.L., Metcalf D., Corbin J.E., Adams T.E., Davey H.W., et al. Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). Mo.l Endocrinol. 2002, 16(6):1394-1406.
15. Henry C.J., Huang Y., Wynne A.M., Godbout J.P. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines. Brain Behav. Immun. 2009, 23(3):309-317.
16. Hofmann K.W., Schuh A.F.S., Saute J., Townsend R., Fricke D., Leke R., Souza D.O., et al. Interleukin-6 serum levels in patients with Parkinson's disease. Neurochem. Res. 2009, 34(8):1401-1404.
17. Klapproth J., Castell J., Geiger T., Andus T., Heinrich P.C. Fate and biological action of human recombinant interleukin 1 beta in the rat in vivo. Eur. J. Immunol. 1989, 19(8):1485-1490.
18. Leoutsakos J.-M.S., Muthen B.O., Breitner J.C.S., Lyketsos C.G. Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial. Int. J. Geriatr. Psychiatry 2012, 27(4):364-374.
19. Li Z., Li J., Bu X., Liu X., Tankersley C.G., Wang C., Huang K. Age-induced augmentation of p38 MAPK phosphorylation in mouse lung. Exp. Gerontol. 2011, 46(8):694-702.
20. Machado F.S., Johndrow J.E., Esper L., Dias A., Bafica A., Serhan C.N., Aliberti J. Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nat. Med. 2006, 12(3):330-334. 10.1038/nm1355.
21. Melief J., Koning N., Schuurman K.G., Van De Garde M.D.B., Smolders J., Hoek R.M., Van Eijk M., et al. Phenotyping primary human microglia: tight regulation of LPS responsiveness. Glia 2012, 60(10):1506-1517.
22. Ochoa J.B., Bernard A.C., O'Brien W.E., Griffen M.M., Maley M.E., Rockich A.K., Tsuei B.J., et al. Arginase I expression and activity in human mononuclear cells after injury. Ann. Surg. 2001, 233(3):393-399.
23. Sheng J.G., Jones R.A., Zhou X.Q., McGinness J.M., Van Eldik L.J., Mrak R.E., Griffin W.S. Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation. Neurochem. Int. 2001, 39(5-6):341-348.
24. Smith J.A., Das A., Ray S.K., Banik N.L. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res. Bull. 2012, 87:10-20.
25. Stoecklin G., Anderson P. Posttranscriptional mechanisms regulating the inflammatory response. Adv. Immunol. 2006, 89:1-37.
26. Sudduth T.L., Schmitt F.A., Nelson P.T., Wilcock D.M. Neuroinflammatory phenotype in early Alzheimer's disease. Neurobiol. Aging 2013, 34(4):1051-1059.
27. Wang J.P., Campbell I.L. Cytokine signaling in the brain: putting a SOCS in it?. Journal of neuroscience research 2002, 67(4):423-427.
28. Wei R., Jonakait G.M. Neurotrophins and the anti-inflammatory agents interleukin-4 (IL-4), IL-10, IL-11 and transforming growth factor-beta1 (TGF-beta1) down-regulate T cell costimulatory molecules B7 and CD40 on cultured rat microglia. J. Neuroimmunol. 1999, 95(1-2):8-18.